- Corporate Officers - G
- Gordon Christopher R
Insider Trading History of Gordon Christopher R
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Gordon Christopher R since 2011.
This trader's CIK number is 1432313.
At the time of last reporting, Gordon Christopher R was the Director of Cerevel Therapeutics Holdings, Inc.. (stock ticker symbol CERE).
Also see all insider trading activities at Cerevel Therapeutics Holdings, Inc..
Note that in the past
Gordon Christopher R also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Cerevel Therapeutics Holdings, Inc. (CERE) by Gordon Christopher R
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | CERE | 5,480,052 | $124,999,986 | 0 | $0 | 0 | $0 |
| 2020 | CERE | 10,332,293 | $103,422,617 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Acadia Healthcare Company, Inc. (ACHC) by Gordon Christopher R
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2017 | ACHC | 0 | $0 | 3,452,202 | $177,347,732 | 0 | $0 |
| 2015 | ACHC | 0 | $0 | 2,351,137 | $189,195,994 | 0 | $0 |
Yearly summary of insider trading at Iqvia Holdings Inc. (Q) by Gordon Christopher R
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2015 | Q | 0 | $0 | 5,368,632 | $378,163,620 | 0 | $0 |
| 2014 | Q | 0 | $0 | 7,923,941 | $428,014,303 | 0 | $0 |
| 2013 | Q | 0 | $0 | 2,531,393 | $95,686,655 | 0 | $0 |
Yearly summary of insider trading at Hca Healthcare, Inc. (HCA) by Gordon Christopher R
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2013 | HCA | 0 | $0 | 38,157,406 | $1,529,824,954 | 0 | $0 |
| 2012 | HCA | 0 | $0 | 15,033,063 | $496,091,079 | 0 | $0 |
| 2011 | HCA | 0 | $0 | 15,619,633 | $451,610,448 | 0 | $0 |
Insider trading activities at 4 companies by Gordon Christopher R:
1. Cerevel Therapeutics Holdings, Inc. (CERE)
2. Acadia Healthcare Company, Inc. (ACHC)
3. Iqvia Holdings Inc. (Q)
4. Hca Healthcare, Inc. (HCA)
Table 1. Insider trading of Cerevel Therapeutics Holdings, Inc. (CERE) by Gordon Christopher R
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-10-16 | CERE | Buy | 5,480,052 | 22.81 | 124,999,986 |
| 2020-11-09 | CERE | Buy | 332,293 | 10.30 | 3,422,617 |
| 2020-10-27 | CERE | Buy | 10,000,000 | 10.00 | 100,000,000 |
Table 2. Insider trading of Acadia Healthcare Company, Inc. (ACHC) by Gordon Christopher R
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2017-08-22 | ACHC | Sale | 998,438 | 50.69 | 50,610,822 |
| 2017-07-31 | ACHC | Sale | 2,453,764 | 51.65 | 126,736,910 |
| 2015-08-14 | ACHC | Sale | 2,351,137 | 80.47 | 189,195,994 |
Table 3. Insider trading of Iqvia Holdings Inc. (Q) by Gordon Christopher R
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2015-08-05 | Q | Sale | 2,396,792 | 77.37 | 185,439,797 |
| 2015-05-19 | Q | Sale | 2,971,840 | 64.85 | 192,723,823 |
| 2014-11-10 | Q | Sale | 3,773,886 | 58.09 | 219,225,037 |
| 2014-03-26 | Q | Sale | 570,682 | 50.31 | 28,711,011 |
| 2014-03-18 | Q | Sale | 3,579,373 | 50.31 | 180,078,255 |
| 2013-05-14 | Q | Sale | 2,531,393 | 37.80 | 95,686,655 |
Table 4. Insider trading of Hca Healthcare, Inc. (HCA) by Gordon Christopher R
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2013-11-01 | HCA | Sale | 14,580,887 | 46.92 | 684,135,218 |
| 2013-02-15 | HCA | Sale | 23,576,519 | 35.87 | 845,689,736 |
| 2012-12-14 | HCA | Sale | 15,033,063 | 33.00 | 496,091,079 |
| 2011-03-15 | HCA | Sale | 15,619,633 | 28.91 | 451,610,448 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Gordon Christopher R
(Director of Cerevel Therapeutics Holdings, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.